Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

amcenestrant

An orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, SERD SAR439859 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:selective estrogen receptor degrader SAR439859
selective estrogen receptor downregulator SAR439859
SERD SAR439859
Code name:SAR 439859
SAR-439859
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search